Dalton, Greiner, Hartman, Maher & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Dalton, Greiner, Hartman, Maher & Co’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,167	Closed	-$669K	–	95
2021 Q1	$669K	Sell	15,167 -103,893	-87%	-$4.37M	0.53%	82
2020 Q4	$4.15M	Sell	119,060 -60,288	-34%	-$2.14M	0.87%	55
2020 Q3	$6.53M	Sell	179,348 -123,633	-41%	-$4.6M	1.07%	32
2020 Q2	$11.4M	Sell	302,981 -37,043	-11%	-$1.48M	1.12%	25
2020 Q1	$12.5M	Sell	340,024 -4,107	-1%	-$160K	1.3%	18
2019 Q4	$13.9M	Sell	344,131 -29,731	-8%	-$1.11M	0.95%	38
2019 Q3	$13M	Buy	373,862 +3,143	+0.8%	+$104K	0.89%	42
2019 Q2	$11.7M	Sell	370,719 -7,847	-2%	-$233K	0.98%	39
2019 Q1	$11.3M	Sell	378,566 -56,236	-13%	-$1.61M	0.95%	47
2018 Q4	$13.4M	Sell	434,802 -9,939	-2%	-$363K	1%	43
2018 Q3	$16.9M	Buy	+444,741	New	+$16.8M	0.84%	55

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.56B AUM 1.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co's PBH Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Prestige Consumer Healthcare (PBH) in Q2 2021, closing a stake of 15,167 shares — an estimated $669K sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in PBH in Q3 2018 and held it in 11 quarters. The position peaked at $16.9M in Q3 2018. 228 funds tracked by Wall St. Rank hold PBH as of Q2 2021.

Dalton, Greiner, Hartman, Maher & Co reported no remaining Prestige Consumer Healthcare position as of Q2 2021 after selling out during the quarter.
Dalton, Greiner, Hartman, Maher & Co sold 15,167 Prestige Consumer Healthcare shares in Q2 2021, an estimated $669K.
Dalton, Greiner, Hartman, Maher & Co first reported a position in Prestige Consumer Healthcare in Q3 2018 and held it in 11 quarters.
Dalton, Greiner, Hartman, Maher & Co's Prestige Consumer Healthcare position peaked at $16.9M in Q3 2018.
228 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.